SIGNORET PHARMACEUTICALS PRIVATE LIMITED

In their own words

Signoret Pharmaceuticals Private Limited, founded in 2019, is a growth-driven pharmaceutical company dedicated to improving global healthcare outcomes through high-quality, innovative, and affordable medicines. We specialize in the manufacturing and commercialization of tablets, liquids, and capsules, catering to a wide range of therapeutic categories including pain management, antibiotics, gastrointestinal disorders, and cardiovascular health. With GMP-certified facilities and a strong focus on research and development, we continuously invest in advanced technologies, novel formulations, and efficient drug delivery systems that enhance patient compliance and treatment outcomes. Our diverse portfolio includes immediate and controlled-release tablets, oral solutions, suspensions, and hard gelatin as well as delayed-release capsules, addressing both chronic and acute healthcare needs. Backed by a proven track record of regulatory compliance and successful market presence across India, we are now expanding our footprint into emerging global markets through strategic partnerships and distribution networks. Our vision is to be a global leader in pharmaceutical formulations while creating sustainable value for patients, healthcare professionals, and shareholders. Financially strong with consistent double-digit revenue and profit growth, Signoret Pharmaceuticals is preparing for its next phase of expansion through an Initial Public Offering (IPO). The proceeds will drive manufacturing capacity enhancement, R&D initiatives in critical areas such as antibiotics, neurology, and diabetes, global market penetration, and strategic acquisitions. At Signoret Pharmaceuticals, our mission is clear: to make safe, effective, and innovative medicines accessible worldwide—improving lives and building a healthier future.

Written by the company on its public Startup India profile. Not verified by us.